Argon Medical Devices has entered into a definitive license agreement with Rex Medical for exclusive global rights to market and distribute the Option Retrievable Inferior Vena Cava Filter.
Option Retrievable Inferior Vena Cava Filter is an implantable device used in the prevention of Pulmonary Embolism (PE).
Argon Medical Devices president George Leondis said are pleased with the addition of Option to our product portfolio. This proven technology has rapidly become a leader in this disease segment due both to its efficacy and safety, and we are confident it will prove to be the preferred device of its kind.
"This partnership provides a compelling strategic opportunity for Argon, allowing us to provide our customers with another best in class product in the Interventional arena," Leondis said.
Rex Medical president Lindsay Carter said Rex Medical is looking forward to again collaborating with Argon, on this innovative and pivotal technology.
"Argon’s focused commitment to its customer base, coupled with its global sales and marketing presence and corresponding operational capabilities, make it the ideal partner," Carter said.